These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31841587)

  • 1. Insights into channel modulation mechanism of RYR1 mutants using Ca2+ imaging and molecular dynamics.
    Yamazawa T; Ogawa H; Murayama T; Yamaguchi M; Oyamada H; Suzuki J; Kurebayashi N; Kanemaru K; Oguchi K; Sakurai T; Iino M
    J Gen Physiol; 2020 Jan; 152(1):. PubMed ID: 31841587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC; Holford TW; Yamaguchi N
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
    Dirksen RT; Avila G
    Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes.
    Tsuboi Y; Oyama K; Kobirumaki-Shimozawa F; Murayama T; Kurebayashi N; Tachibana T; Manome Y; Kikuchi E; Noguchi S; Inoue T; Inoue YU; Nishino I; Mori S; Ishida R; Kagechika H; Suzuki M; Fukuda N; Yamazawa T
    J Gen Physiol; 2022 Nov; 154(11):. PubMed ID: 36200983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region.
    Murayama T; Kurebayashi N; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    PLoS One; 2015; 10(6):e0130606. PubMed ID: 26115329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area.
    Bannister ML; Hamada T; Murayama T; Harvey PJ; Casarotto MG; Dulhunty AF; Ikemoto N
    Biochem J; 2007 Jan; 401(1):333-9. PubMed ID: 16958617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion-pulling simulations provide insights into the mechanisms of channel opening of the skeletal muscle ryanodine receptor.
    Mowrey DD; Xu L; Mei Y; Pasek DA; Meissner G; Dokholyan NV
    J Biol Chem; 2017 Aug; 292(31):12947-12958. PubMed ID: 28584051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of amino-terminal half of the S4-S5 linker in type 1 ryanodine receptor (RyR1) channel gating.
    Murayama T; Kurebayashi N; Oba T; Oyamada H; Oguchi K; Sakurai T; Ogawa Y
    J Biol Chem; 2011 Oct; 286(41):35571-35577. PubMed ID: 21862589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels.
    Bannister RA; Estève E; Eltit JM; Pessah IN; Allen PD; López JR; Beam KG
    J Gen Physiol; 2010 Jun; 135(6):629-40. PubMed ID: 20479108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.
    Murayama T; Oba T; Hara H; Wakebe K; Ikemoto N; Ogawa Y
    Biochem J; 2007 Mar; 402(2):349-57. PubMed ID: 17107340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
    Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
    J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.
    Truong KM; Pessah IN
    Toxicol Sci; 2019 Feb; 167(2):509-523. PubMed ID: 30329129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor.
    Kobayashi S; Yamamoto T; Parness J; Ikemoto N
    Biochem J; 2004 Jun; 380(Pt 2):561-9. PubMed ID: 15027895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients.
    Oyamada H; Oguchi K; Saitoh N; Yamazawa T; Hirose K; Kawana Y; Wakatsuki K; Oguchi K; Tagami M; Hanaoka K; Endo M; Iino M
    Jpn J Pharmacol; 2002 Feb; 88(2):159-66. PubMed ID: 11928716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired interaction between skeletal ryanodine receptors in malignant hyperthermia.
    Liang X; Chen K; Fruen B; Hu J; Ma J; Hu X; Parness J
    Integr Biol (Camb); 2009 Sep; 1(8-9):533-9. PubMed ID: 20023768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.